Vol 4 n° 4 - Drug Development
Past issues Contributors How to publish Contributions and comments Home
 
lthough the pathophysiology of schizophrenia remains unknown, clues about its mechanisms are emerg- ing.1 It is one of the most studied human illnesses in the field of neuroscience. Moreover, the most sophisticated modern  techniques  have  been  brought  to  bear  on answering  its  question:  cellular  and  molecular  tech- niques,2,3 genetics,4 and in vivo imaging.5 We know that it is a complex genetic illness with little gross pathology or replicated markers of dysfunction. Investigators in our laboratory, among others, have been studying the localization of functional pathology in this illness. In the future, this information will allow a more detailed histological, cellular, and molecular examination of changes in those target regions. Moreover, it will pro- vide an experimental framework for future studies of drug action and family studies. Limbic cortex: the ACC and the HC Our first suggestion that the limbic cortex could be a player in the functional pathology of schizophrenia came from the correlation that we identified between neuronal activity in the anterior cingulate cortex (ACC) and hip- pocampus (HC) (measured by [18F]deoxyglucose positron emission tomography) and the magnitude of psychosis score (measured on the Brief Psychiatric Rating Scale [BPRS]) (r=0.590; P=0.03).This correlation between psy- chosis and neuronal activity was only obtained when the study volunteers were drug-free, but was entirely obscured Keywords: schizophrenia; limbic cortex; anterior cingulate cortex; hippocampus; antipsychotic medication Author  affiliations:  Maryland  Psychiatric  Research  Center,  Department  of Psychiatry, University of Maryland School of Medicine, Baltimore, Md, USA Address   for   correspondence:   Carol   A.   Tamminga,   Maryland   Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Box 21247, Baltimore, MD 21228, USA (e-mail: ctamming@mprc.umaryland.edu) P h a r m a c o l o g i c a l   a s p e c t s 4 3 2 Studies in schizophrenia: pathophysiology and treatment Carol A. Tamminga, MD; Deborah R. Medoff, PhD A Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first,   we   describe   a   positive   significant   correlation between psychotic symptoms in schizophrenia and neu- ronal activity in the ACC and HC, suggesting the involve- ment of limbic cortex in the mediation of symptoms in schizophrenia. Second, in the ACC and the anterior HC (but not in the posterior HC), regional cerebral blood flow (rCBF) is abnormal (ie, reduced in the ACC and elevated in the HC) in schizophrenia. Third, the relationship of rCBF to task difficulty in the ACC is altered in schizophrenia, suggesting a failure of participation of the ACC in effort- ful tasks. Lastly, connectivity between the ACC and HC during the performance of an auditory discrimination task is also lacking, suggesting that cognitive performance in schizophrenia lacks a functional limbic contribution. On the  basis  of  these  changes,  we  studied  the  effects  of antipsychotic drugs in these abnormal areas in persons with schizophrenia. Both first- and second-generation antipsychotics produce functional alterations in these lim- bic cortical areas, in the direction of normals, putatively acting through the brain’s own cortical-subcortical circuits. Dialogues Clin Neurosci. 2002;4:432-437.